Improving medication adherence in children with leukemia through parenting skills
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
NA · Roswell Park Cancer Institute · NCT06074666
This study is testing a new program to help parents of young children with leukemia make sure their kids take their medicine regularly.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 3 Years to 9 Years |
| Sex | All |
| Sponsor | Roswell Park Cancer Institute (other) |
| Locations | 1 site (Buffalo, New York) |
| Trial ID | NCT06074666 on ClinicalTrials.gov |
What this trial studies
This pilot randomized controlled trial evaluates the CareMeds intervention aimed at enhancing medication adherence among young children (ages 3-9) diagnosed with acute lymphoblastic leukemia (ALL). The study will involve 100 families across multiple sites in Buffalo, NY, and Atlanta, GA, comparing the CareMeds program to usual care. The primary focus is to assess the feasibility of the intervention and gather preliminary efficacy data on behavioral parenting skills and medication adherence. Parents will be actively involved, as they hold primary responsibility for their child's medication management.
Who should consider this trial
Good fit: Ideal candidates are parents of children aged 3-9 years who are diagnosed with acute lymphoblastic leukemia and are responsible for their child's medication.
Not a fit: Patients whose children are not diagnosed with acute lymphoblastic leukemia or are not on home-based oral anti-cancer medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve medication adherence in pediatric patients with leukemia, leading to better health outcomes.
How similar studies have performed: Other studies have shown promise in improving medication adherence through behavioral interventions, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site. * Parent has primary medication responsibility. * Pediatric patient aged 3-9 years * Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP. * Parent has verbal English or Spanish fluency. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * Parent is unwilling or unable to follow protocol requirements
Where this trial is running
Buffalo, New York
- Roswell Park Comprehensive Cancer Center — Buffalo, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Elizabeth Bouchard, PhD — Roswell Park Comprehensive Cancer Center
- Study coordinator: Elizabeth Bouchard, PhD
- Email: Elizabeth.Bouchard@roswellpark.rog
- Phone: 716-845-1300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Lymphoblastic Leukemia, Pediatric